Viking Global Investors Teva Pharma Industries Ltd ADR transactions over time
TEVA-OLD
Teva Pharma Industries Ltd ADR historical holders
total: 10
Transactions details
- Total transactions:
- 14
- New positions:
- 3
- Sold out:
- 3
- Added:
- 4
- Reduced:
- 4
- Held since:
- 2024 Q3
- Held for:
- 5 quarters
- Latest activity:
- 2025 Q4
Ole Andreas Halvorsen has been an institutional investor in Teva Pharma Industries Ltd ADR (TEVA-OLD) since 2015 Q1. According to 2026 Q2 report, Ole Andreas Halvorsen doesn't hold any shares. The fund/company first acquired TEVA-OLD in 2015 Q1, initially purchasing 228,600 shares. Ole Andreas Halvorsen later completely sold out the position and reinvested in TEVA-OLD again in 2024 Q3. Since the initial investment, Viking Global Investors has made 13 more transactions in this position.
When did Ole Andreas Halvorsen exit their TEVA-OLD position?
Ole Andreas Halvorsen no longer holds Teva Pharma Industries Ltd ADR (TEVA-OLD). They sold off their entire position in 2025 Q4, closing out an investment that began in 2015 Q1.
When did Ole Andreas Halvorsen first invest in TEVA-OLD?
Ole Andreas Halvorsen first invested in Teva Pharma Industries Ltd ADR (TEVA-OLD) in 2015 Q1 at the reported quarter-end price of $62.30 per share, acquiring 228,600 shares in their initial purchase.
What is Ole Andreas Halvorsen's average cost basis for TEVA-OLD?
Based on historical transaction data, Ole Andreas Halvorsen's estimated cost basis for Teva Pharma Industries Ltd ADR (TEVA-OLD) is approximately $17.11 per share. This represents their average reported price* across all buy transactions.
Has Ole Andreas Halvorsen reinvested in TEVA-OLD after selling?
Yes, Ole Andreas Halvorsen has shown renewed interest in Teva Pharma Industries Ltd ADR (TEVA-OLD). After completely selling their position, they reinitiated an investment in 2024 Q3, demonstrating continued conviction in this ticker.
Estimated cost basis*
- Weighted AVG buy price:
- $17.11
- Weighted AVG sell price:
- $20.35
TEVA-OLD transactions history by Viking Global Investors
14 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2025 Q4
|
0.00%
|
0
|
$20.20
|
|
-100% (-2,532,119)
|
-0.13%
|
|
2025 Q3
|
0.13%
|
2,532,119
|
$20.20
|
$51,148,804
|
-78.32% (-9,149,214)
|
-0.53%
|
|
2025 Q2
|
0.57%
|
11,681,333
|
$16.76
|
$195,779,141
|
+15.37% (+1,555,855)
|
+0.08%
|
|
2025 Q1
|
0.49%
|
10,125,478
|
$15.37
|
$155,628,597
|
+55.69% (+3,621,993)
|
+0.18%
|
|
2024 Q4
|
0.46%
|
6,503,485
|
$22.04
|
$143,336,809
|
-14.06% (-1,064,048)
|
-0.09%
|
|
2024 Q3
|
0.50%
|
7,567,533
|
$18.02
|
$136,366,945
|
new
|
+0.5%
|
|
2016 Q4
|
0.00%
|
$46.01
|
-100% (-19,684,219)
|
|||
|
2016 Q3
|
3.91%
|
$46.01
|
-29.03% (-8,052,436)
|
|||
|
2016 Q2
|
5.92%
|
$50.23
|
-15.88% (-5,234,967)
|
|||
|
2016 Q1
|
7.77%
|
$53.51
|
+31.66% (+7,927,847)
|
|||
|
2015 Q4
|
6.20%
|
$65.64
|
+182.26% (+16,171,125)
|
|||
|
2015 Q3
|
1.92%
|
$56.46
|
new
|
|||
|
2015 Q2
|
0.00%
|
$62.30
|
-100% (-228,600)
|
|||
|
2015 Q1
|
0.06%
|
$62.30
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.